The topical administration of bisphosphonates in implant surgery: A randomized split-mouth prospective study with a follow-up up to 5 years

Clinical Implant Dentistry and Related Research

Volumn 17, Issue S1, 2015, Pages e168-e176

  Zuffetti, Francesco ^a   Testori, Tiziano ^a   Capelli, Matteo ^a   Rossi, Maria Cristina ^a   Del Fabbro, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bisphosphonates; Dental implants; Edentulism

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; TOOTH IMPLANT;

ADULT; AGED; CONTROLLED STUDY; FEMALE; HUMAN; JAW, EDENTULOUS; JAW, EDENTULOUS, PARTIALLY; MALE; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TOOTH IMPLANT; TOOTH IMPLANTATION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DIPHOSPHONATES; FEMALE; HUMANS; JAW, EDENTULOUS; JAW, EDENTULOUS, PARTIALLY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85028279645     PISSN: 15230899     EISSN: 17088208     Source Type: Journal    
DOI: 10.1111/cid.12151     Document Type: Article

References (58)

1. Park JY, Davies JE. Red blood cell and platelet interactions with titanium implant surfaces. Clin Oral Implants Res 2000; 11:530-539.
2. Sul YT, Johansson C, Albrektsson T. Which surface properties enhance bone response to implants? Comparison of oxidized magnesium, TiUnite, and Osseotite implant surfaces. Int J Prosthodont 2006; 19:319-328.
3. Tach RM, Kohles SS. A meta-analysis examining the clinical survivability of machined-surfaced and Osseotite implants in poor-quality bone. Implant Dent 2003; 12:87-96.
4. Testori T, Wiseman L, Woolfe S, Porter SS. A prospective multicenter clinical study of the Osseotite implant: four-year interim report. Int J Oral Maxillofac Implants 2001; 16:193-200.
5. Buser D, Schenk RK, Steinemann S, etal. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res 1991; 25:889-902.
6. Engquist B, Åstrand P, Dahlgren S, etal. Marginal bone reaction to oral implants: a prospective comparative study of Astra Tech and Brånemark implant system implants. Clin Oral Implants Res 2002; 13:30-37.
7. Astrand P, Engquist B, Dahlgren S, etal. Astra Tech and Brånemark implant system implants: a prospective 5-year comparative study. Results after one year. Clin Implant Dent Relat Res 1999; 1:17-26.
8. Van Steenberghe D, De Mars G, Quirynen M, etal. A prospective split-mouth comparative study of two screw-shaped selftapping pure titanium implant systems. Clin Oral Implants Res 2000; 11:202-209.
9. Anitua EA. Enhancement of osseointegration by generating a dynamic implant surface. J Oral Implantol 2006; 32:72-76.
10. Anitua E, Orive G, Aguirre JJ, etal. 5-year clinical experience with BTI dental implants: risk factors for implant failure. J Clin Periodontol 2008; 35:724-732.
11. Arora NS, Ramanayake T, Ren Y-F, etal. Platelet-rich plasma: a literature review. Implant Dent 2009; 18:303-310.
12. Del Fabbro M, Bortolin M, Taschieri S, etal. Effect of autologous growth factors in maxillary sinus augmentation. A systematic review. Clin Implant Dent Relat Res 2013; 15:205-216.
13. Liu Y, Enggist L, Kuffer AF, etal. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials 2007; 28:2677-2686.
14. Schliephake H, Aref A, Scharnweber D, etal. Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. Clin Oral Implants Res 2005; 16:563-569.
15. Becker J, Kirsch A, Schwarz F, etal. Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs. Clin Oral Invest 2006; 10:217-224.
16. Wikesjö UME, Huang YH, Xiropaidis AV, etal. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (type IV bone) in non-human primates. J Clin Periodontol 2008; 35:992-1000.
17. Wikesjö UME, Xiropaidis AV, Qahash M, etal. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (type II bone) in dogs. J Clin Periodontol 2008; 35:985-991.
18. Kaigler D, Avila G, Wisner-Lynch L, etal. Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Expert Opin Biol Ther 2011; 11:375-385.
19. Nevins ML, Reynolds MA. Tissue engineering with recombinant human platelet-derived growth factor BB for implant site development. Compend Contin Educ Dent 2011; 32:20-27.
20. Ayukawa Y, Okamura A, Koyano K. Simvastatin promotes osteogenesis around titanium implants. Clin Oral Implants Res 2004; 15:346-350.
21. Moriyama Y, Ayukawa Y, Ogino Y, etal. Topical application of statin affects bone healing around implants. Clin Oral Implants Res 2008; 19:600-605.
22. Ayukawa Y, Ogino Y, Moriyama Y, etal. Simvastatin enhances bone formation around titanium implants in rat tibiae. J Oral Rehabil 2010; 37:123-130.
23. Mair B, Tangl S, Feierfeil J, etal. Age-related efficacy of parathyroid hormone on osseointegration in the rat. Clin Oral Implants Res 2009; 20:400-405.
24. Kuchler U, Spilka T, Baron K, etal. Intermittent parathyroid hormone fails to stimulate osseointegration in diabetic rats. Clin Oral Implants Res 2011; 22:518-523.
25. Schliephake H, Scharnweber D, Dard M, etal. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest. An experimental pilot study in dogs. Clin Oral Implants Res 2002; 13:312-319.
26. Jung RE, Cochran DL, Domken O, etal. The effect of matrix bound parathyroid hormone on bone regeneration. Clin Oral Implants Res 2007; 18:319-325.
27. Avila G, Misch K, Galindo-Moreno P, Wang HL. Implant surface treatment using biomimetic agents. Implant Dent 2009; 18:17-26.
28. Junker R, Dimakis A, Thoneick M, Jansen JA. Effects of implant surface coatings and composition on bone integration: a systematic review. Clin Oral Implants Res 2009; 20(Suppl 4):185-206.
29. Cho YJ, Heo SJ, Koak JY, etal. Promotion of osseointegration of anodized titanium implants with a 1α, 25-dihydroxyvitamin D3 submicron particle coating. Int J Oral Maxillofac Implants 2011; 26:1225-1232.
30. Merav SJ, Reeve CM, Wollan PC. Use of alendronate in peri-implant defect regeneration. J Periodontol 1999; 70:151-158.
31. Merav SJ, Reeve CM. Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration. J Periodontol 1999; 70:1228-1233.
32. Yoshinari M, Oda Y, Inoue T, etal. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants. Biomaterials 2002; 23:2879-2885.
33. Narai S, Nagahata S. Effects of alendronate on the removal torque of implants in rats with induced osteoporosis. Int J Oral Maxillofac Implants 2003; 18:218-223.
34. Skoglund B, Holmerz J, Aspenberg P. Systemic and local ibandronate enhances screw fixation. J Orthop Res 2004; 22:1108-1113.
35. Tengvall P, Skoglund B, Askendal A, etal. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004; 25:2133-2138.
36. Kurth AH, Eberhardt C, Müller S, etal. The bisphosphonate ibandronate improves implant integrarion in osteopenic ovariectomized rats. Bone 2005; 37:204-210.
37. Kajiwara H, Yamaza T, Yoshinari M, etal. The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats. Biomaterials 2005; 26:581-587.
38. Chacon GE, Stine EA, Larsen PE, etal. Effect of alendronate on endosseous implant integration: an in vivo study in rabbits. J Oral Maxillofac Surg 2006; 64:1005-1009.
39. Aspenberg P. Bisphosphonates and implants: an overview. Acta Orthop 2009; 80:119-123.
40. Zuffetti F, Bianchi F, Volpi R, etal. Clinical application of bisphosphonates in implant dentistry: histomorphometric evaluation. Int J Periodontics Restorative Dent 2009; 29:31-39.
41. Abtahi J, Tengvall P, Aspenberg P. Bisphosphonate coating might improve fixation of dental implants in the maxilla: a pilot study. Int J Oral Maxillofac Surg 2010; 39:673-677.
42. Abtahi J, Tengvall P, Aspenberg P. A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone 2012; 50:1148-1151.
43. Fleisch H. Bisphosphonates: mechanism of action. Endocr Rev 1998; 19:80-100.
44. Reszka AA, Rodan GA. Mechanism of action of bisphosphonates. Curr Osteoporos Rep 2003; 1:45-52.
45. Javed F, Almas K. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review. J Periodontol 2010; 81:479-484.
46. Tenenbaum HC, Shelemay A, Girard B, etal. Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses. J Periodontol 2002; 73:813-822.
47. Väänänen K. Mechanism of osteoclast mediated bone resorption: rationale for the design of new therapeutics. Adv Drug Deliv Rev 2005; 57:959-971.
48. Del Fabbro M, Testori T, Francetti L, etal. A systematic review of survival rates for immediately loaded dental implants. Int J Periodontics Restorative Dent 2006; 26:249-263.
49. Buser D, Mericske-Stern R, Bernard JP, etal. Long-term evaluation of nonsubmerged ITI implants. Part 1: 8-year life table analysis of a prospective multi-center study with 2359 implants. Clin Oral Implants Res 1997; 8:161-172.
50. Cochran D, Buser D, TenBruggenkate C, etal. The use of reduced healing times on ITI implants with a sandblasted and acid-etched (SLA) surface. Clin Oral Implants Res 2002; 13:144-153.
51. Jaffin RA, Berman CL. The excessive loss of Brånemark fixtures in type IV bone: a 5-year analysis. J Periodontol 1991; 62:2-4.
52. Testori T, Volpi R, Del Fabbro M, etal. Prospective multicenter study on the topical use of sodium clodronate in implant surgery. Implantologia Orale 2001; 4:79-84.
53. Zuffetti F, Bianchi F, Volpi R, etal. Clinical use of bisphosphonates in dentistry: histomorphometric evaluation. Implantologia Orale 2007; 1:30-36.
54. Jeffcoat MK. Safety of bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006; 21:349-353.
55. Zahid TM, Wang BY, Cohen RE. Influence of bisphosphonates on alveolar bone loss around osseointegrated implants. J Oral Implantol 2011; 37:335-346.
56. Pjetursson BE, Zwahlen M, Lang NP. Quality of reporting of clinical studies to assess and compare performance of implant-supported restorations. J Clin Periodontol 2012; 39(Suppl. 12):139-159.
57. Woo S-B, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Int Med 2006; 144:753-761.
58. Otomo-Corgel J. Implants and oral bisphosphonates: risky business. J Periodontol 2007; 78:373-376.